Results 151 to 160 of about 76,161 (283)
Antithrombotic therapy for transcatheter structural heart intervention.
Percutaneous transcatheter structural heart interventions have considerably expanded within the last two decades, improving clinical outcomes and quality of life versus guideline-directed medical therapy for patients frequently ineligible for surgical ...
Rodés-Cabau, Josep +9 more
core +1 more source
The FASEB Journal, Volume 40, Issue 11, 15 June 2026.Direct RNA sequencing of primary human valvular interstitial cells (VICs) from non‐calcified control and fibro‐calcific aortic stenosis (AS) valves reveals disease‐associated remodeling of m6A RNA methylation. AS‐derived VICs show an overall increase in detected m6A sites, together with transcript‐specific hyper‐ and hypo‐methylation patterns ...
Vincenza Valerio +6 more
wiley +1 more source
Emergency transcatheter aortic valve implantation for decompensated aortic stenosis
, 2013 We report the case of an 84-year-old male presenting with syncope and dynamic ST-T wave changes due to decompensated severe valvular aortic stenosis undergoing successful emergency transcatheter aortic valve ...
Pilgrim, Thomas +2 more
core
Catheterization and Cardiovascular Interventions, Volume 107, Issue 7, Page 2179-2182, June 1, 2026.ABSTRACT Paravalvular leak (PVL) is a recognized complication after surgical mitral valve replacement and may cause heart failure, pulmonary hypertension, or hemolysis when moderate or severe. Although redo surgery is the definitive treatment, it carries substantial risk in elderly patients or those with multiple prior cardiac surgeries.
Marco Garaventa +3 more
wiley +1 more source
A Narrative Review of the Evidence for Transcatheter Aortic Valve Implants
Currently, multiple transcatheter aortic valves exist in clinical use, with varying efficacy and safety rates. This review aims to evaluate the evidence base for current transcatheter valves used in the management of aortic stenosis in Australia to ...
Liew, Danny +5 more
core +1 more source
Outcomes of Left Atrial Appendage Occlusion in Heart Failure With Reduced Ejection Fraction
Catheterization and Cardiovascular Interventions, Volume 107, Issue 7, Page 2345-2352, June 1, 2026.ABSTRACT Background Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from major trials of left atrial appendage occlusion (LAAO). Aim The objective of this study was to describe this population and evaluate outcomes after LAAO in patients with and without HFrEF.
Aamer Ubaid +4 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Stent‐related dissection is a well‐recognized complication of endovascular intervention. However, acute arterial occlusion resulting from stent‐induced intimal flap displacement at a major bifurcation is rare and carries a high risk of limb‐threatening ischemia.
Le Zhang +4 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Rupture of renal artery aneurysm during pregnancy (PSRRAA) is a life‐threatening emergency that can lead to adverse outcomes for both the mother and the fetus. This paper reports a case of right renal artery aneurysm (RAA) rupture in a 32‐year‐old pregnant woman at 37 weeks of gestation, and discusses the clinical diagnosis and treatment of ...
SuFang Qiu +3 more
wiley +1 more source
Clinical Cardiology, Volume 49, Issue 6, June 2026.Artificial intelligence demonstrates strong diagnostic accuracy for detecting tricuspid regurgitation, particularly with echocardiography‐based models. Despite promising performance, substantial heterogeneity and limited external validation highlight the need for prospective, multicenter studies before routine clinical implementation.
Pooya Eini +3 more
wiley +1 more source
Transcatheter mitral valve repair with the PASCAL precision system: First case in Singapore
Severe mitral regurgitation (MR) is associated with significant mortality and morbidity when left untreated.1 In patients who are not suitable for surgery, transcatheter edge-to-edge repair (TEER) provides a minimally-invasive therapeutic option.
Khung Keong Yeo +4 more
core +1 more source